Increased heart attack risk found in osteoporosis drug

New research has confirmed that women who take a new anti-osteoporosis drug could be at an increased risk of having a heart attack.

Osteoporosis causes a loss of bone tissue in some women aged 50 and above.  The condition which causes bones to become weaker and more likely to break, affects 3.5 million people in the UK, including one in five women aged 50 and over, and one in 20 men.

Prescription drug Evenity can strengthen bones, but Bristol Medical School say the medicine could increase the risk of heart attacks by as much as 30 per cent.

UCB, the pharmaceutical firm which manufactures the drug, said safety is at the centre of its work and is examining the findings.

Professor Jon Tobias, professor of rheumatology at Bristol Medical School, said the increased risk depends on a patient’s predisposition.

He added “If you are genetically predisposed to having lower levels of sclerostin, that sees to increase your risk of having calcification in the arteries and also having the risk of heart attack.”

Chadwick Lawrence’s Legal 500 recommended West Yorkshire medical negligence solicitors, have over 20 years of experience and specialist expertise in medical negligence investigations and claims, supporting injured clients and their families through the legal process and helping them obtain answers, justice and compensation after life-changing events.  We have offices in Huddersfield, Wakefield, Halifax, Leeds, Bradford and Morley and represent clients locally and nationally.

If you or a relative have been injured as a result of clinical/medical negligence, please call for free legal advice from our medical negligence lawyers on the freephone number below or e-mail us.

Posted by Karen Motley, Clinical Negligence Department, Chadwick Lawrence LLP (jacquelinevance@chadlaw.co.uk), medical negligence lawyers and clinical negligence solicitors in Huddersfield, Leeds, Wakefield and Halifax, West Yorkshire.

Freephone : 0800 304 7382